Get the Stockscreener App
83.49
0.80%
-0.67
After Hours:
83.49
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Colgate Palmolive Co stock is traded at $83.49, with a volume of 4.94M.
It is down -0.80% in the last 24 hours and down -6.02% over the past month.
Since its founding in 1806, Colgate-Palmolive has grown into a leading player in the household and personal care industry. In addition to its namesake oral care line (which accounts for more than 40% of its total sales), the firm manufactures shampoos, shower gels, deodorants, and home care products sold in over 200 countries. International sales account for about 70% of its total business, including nearly half from emerging regions. It also owns specialty pet food maker Hill's (almost one-fourth of sales), which sells the majority of its products through veterinarians and specialty pet retailers.
See More
Previous Close:
$84.16
Open:
$84
24h Volume:
4.94M
Relative Volume:
0.73
Market Cap:
$66.98B
Revenue:
$20.38B
Net Income/Loss:
$2.26B
P/E Ratio:
31.85
EPS:
2.6214
Net Cash Flow:
$3.63B
1W Performance:
-2.41%
1M Performance:
-6.02%
6M Performance:
+7.55%
1Y Performance:
-11.43%
1-Day Range:
$82.60
$84.36
1-Week Range:
$82.60
$86.40
52-Week Range:
$74.55
$99.33
Colgate Palmolive Co Stock (CL) Company Profile
Name
Colgate Palmolive Co
Sector
Industry
Phone
(212) 310-2000
Address
300 PARK AVE, NEW YORK, NY
Compare CL vs PG, UL, KVUE, KMB
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CL
Colgate Palmolive Co
|
83.49 | 67.52B | 20.38B | 2.26B | 3.63B | 2.6214 |
PG
Procter Gamble Co
|
143.38 | 335.54B | 85.26B | 16.53B | 14.85B | 6.7488 |
UL
Unilever Plc Adr
|
58.09 | 126.25B | 56.67B | 6.96B | 7.39B | 3.1265 |
KVUE
Kenvue Inc
|
17.30 | 33.37B | 15.12B | 1.47B | 1.72B | 0.764 |
KMB
Kimberly Clark Corp
|
96.81 | 32.25B | 17.23B | 1.75B | 1.64B | 6.0654 |
Colgate Palmolive Co Stock (CL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-31-26 | Downgrade | TD Cowen | Buy → Hold |
| Mar-30-26 | Upgrade | Deutsche Bank | Hold → Buy |
| Jan-13-26 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Jan-07-26 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-11-25 | Downgrade | Argus | Buy → Hold |
| Dec-09-25 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Oct-03-25 | Resumed | Piper Sandler | Neutral |
| Oct-28-24 | Downgrade | Stifel | Buy → Hold |
| Sep-24-24 | Initiated | Piper Sandler | Overweight |
| Sep-16-24 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Sep-09-24 | Downgrade | Deutsche Bank | Buy → Hold |
| Jul-26-24 | Downgrade | HSBC Securities | Buy → Hold |
| Jul-24-24 | Downgrade | Jefferies | Buy → Hold |
| Jul-23-24 | Initiated | TD Cowen | Buy |
| Jun-24-24 | Initiated | Exane BNP Paribas | Outperform |
| Mar-01-24 | Resumed | Goldman | Buy |
| Jan-29-24 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Dec-15-23 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-13-23 | Initiated | Jefferies | Buy |
| Oct-16-23 | Upgrade | Stifel | Hold → Buy |
| Sep-22-23 | Initiated | HSBC Securities | Buy |
| Feb-17-23 | Initiated | Citigroup | Buy |
| Jan-30-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Nov-22-22 | Initiated | Wolfe Research | Peer Perform |
| Oct-13-22 | Upgrade | JP Morgan | Neutral → Overweight |
| Aug-01-22 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| May-03-22 | Downgrade | Atlantic Equities | Overweight → Neutral |
| Apr-08-22 | Initiated | Raymond James | Mkt Perform |
| Feb-02-22 | Upgrade | Bernstein | Underperform → Mkt Perform |
| Jan-31-22 | Reiterated | Citigroup | Neutral |
| Jan-31-22 | Reiterated | Credit Suisse | Outperform |
| Jan-31-22 | Reiterated | Deutsche Bank | Buy |
| Jan-31-22 | Reiterated | Morgan Stanley | Equal-Weight |
| Jan-31-22 | Reiterated | Wells Fargo | Underweight |
| Dec-16-21 | Initiated | Redburn | Neutral |
| Oct-05-21 | Resumed | BofA Securities | Neutral |
| Sep-20-21 | Upgrade | Deutsche Bank | Hold → Buy |
| Jun-24-21 | Initiated | UBS | Buy |
| Jun-09-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Feb-01-21 | Upgrade | Credit Suisse | Underperform → Neutral |
| Jan-28-21 | Downgrade | Stifel | Buy → Hold |
| Jan-26-21 | Upgrade | Berenberg | Sell → Hold |
| Jan-20-21 | Initiated | Bernstein | Underperform |
| Jan-04-21 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Dec-08-20 | Initiated | Wells Fargo | Underweight |
| Jul-22-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Mar-27-20 | Upgrade | Stifel | Hold → Buy |
| Mar-27-20 | Upgrade | SunTrust | Hold → Buy |
| Mar-23-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Mar-20-20 | Upgrade | BofA/Merrill | Neutral → Buy |
| Feb-03-20 | Upgrade | Atlantic Equities | Neutral → Overweight |
| Feb-03-20 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Dec-19-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Oct-16-19 | Initiated | Berenberg | Sell |
| Apr-29-19 | Upgrade | JP Morgan | Underweight → Neutral |
| Mar-07-19 | Initiated | Credit Suisse | Underperform |
| Feb-11-19 | Upgrade | Exane BNP Paribas | Underperform → Neutral |
| Jan-11-19 | Initiated | Evercore ISI | Outperform |
| Jan-09-19 | Upgrade | Goldman | Neutral → Buy |
| Oct-29-18 | Downgrade | JP Morgan | Neutral → Underweight |
| Oct-26-18 | Downgrade | SunTrust | Buy → Hold |
| Jul-30-18 | Downgrade | Macquarie | Outperform → Neutral |
| May-25-18 | Upgrade | Argus | Hold → Buy |
| Apr-30-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
View All
Colgate Palmolive Co Stock (CL) Latest News
Colgate (CL) Faces Cautious Outlook as Barclays, BofA Trim Price Targets - Insider Monkey
China's Changing Consumer Economy: A Fintech Lending Crackdown And A Toothpaste IPO - Benzinga
Here is why Colgate-Palmolive (CL) is Among the Best Oversold Blue Chip Stocks to Buy - Insider Monkey
CL DCF Analysis: Intrinsic Value $43 vs Price $84 - GuruFocus
BCS Wealth Management Has $2.03 Million Holdings in Colgate-Palmolive Company $CL - MarketBeat
CL Maintained by Barclays -- Price Target Lowered to $79.00 - GuruFocus
Colgate-Palmolive Co stock (US1941621039): Why dividend reliability matters more now for steady inve - AD HOC NEWS
$2.9M Colgate, Tom’s of Maine contamination class action settlement - Class Action Lawsuits
Colgate-Palmolive Target of Unusually High Options Trading (NYSE:CL) - MarketBeat
Barclays Adjusts Price Target on Colgate-Palmolive to $79 From $88, Maintains Equalweight Rating - marketscreener.com
Oil Prices Face Downward Pressure Amid Easing Iran Conflict Conc - GuruFocus
Sumitomo Mitsui Trust Group Inc. Sells 81,070 Shares of Colgate-Palmolive Company $CL - MarketBeat
If you bought this popular toothpaste, you may be owed money from Colgate-Palmolive. Here's how to claim it - MSN
Massachusetts Financial Services Co. MA Sells 20,407 Shares of Colgate-Palmolive Company $CL - MarketBeat
Bought this toothpaste in the last 6 years? You may qualify for $2.9M settlement - KTLA
How The Colgate Palmolive (CL) Investment Story Is Shifting With New Targets And 2030 Plan - Yahoo Finance
Street Watch: Can Colgate Palmolive Company deliver consistent EPS growth2026 Key Lessons & High Accuracy Trade Signal Alerts - baoquankhu1.vn
Colgate-Palmolive Co (MIL:1CL) Bonds - GuruFocus
Tom's of Maine agrees to $2.9 million settlement over toothpastes. Here's how to claim a payment - The Ridgefield Press
If you bought this toothpaste you could get a check from a $2.9m settlement - the-sun.com
Colgate-Palmolive (NYSE:CL) Price Target Lowered to $102.00 at Bank of America - MarketBeat
Colgate-Palmolive (CL) Analyst Rating Update: Price Target Lowered by B of A | CL Stock News - GuruFocus
CL Stock Price, Quote & Chart | COLGATE-PALMOLIVE CO (NYSE:CL) - ChartMill
Colgate-Palmolive Taps Deputy To Replace Retiring CLO - Law360
Some toothpaste users may be eligible for a payout - KMOV
Tariffs and costs: How exposed is Colgate's 2026 margin outlook? - MSN
If you purchased Tom's toothpaste within the last 6 years, you could be eligible for a payout - MSN
Colgate-Palmolive (CL) Announces Leadership Transition in Legal Department - GuruFocus
Colgate-Palmolive Company 8-K Filing April 2026: Securities Registration and Corporate Information - Minichart
Colgate-Palmolive announces leadership transition in legal department By Investing.com - Investing.com Australia
Colgate-Palmolive announces leadership transition in legal department - Investing.com
Colgate-Palmolive Company Announces Appointment of Betsy Fishbone as Chief Legal Officer and Secretary and Transition of Jennifer M. Daniels to Vice Chair, Effective June 1, 2026 - marketscreener.com
Colgate-Palmolive (CL) plans 2026 transition in top legal leadership - Stock Titan
OFI Invest Asset Management Has $39.72 Million Position in Colgate-Palmolive Company $CL - MarketBeat
Colgate-Palmolive (CL) 10K Form and Latest SEC Filings 2026 - MarketBeat
If you bought this popular toothpaste, you may be owed money from Colgate-Palmolive. Here’s how to claim it - Fast Company
Colgate-Palmolive Co stock: What you should know now amid analyst adjustments - AD HOC NEWS
Wells Fargo Maintains Rating but Lowers Price Target for Colgate-Palmolive (CL) | CL Stock News - GuruFocus
Wells Fargo & Company Lowers Colgate-Palmolive (NYSE:CL) Price Target to $92.00 - MarketBeat
Colgate-Palmolive (CL) Analyst Rating Updates: Piper Sandler Adj - GuruFocus
Tom’s toothpaste settlement: Who qualifies - FOX 8 News
Piper Sandler cuts Colgate-Palmolive stock price target on macro risks - Investing.com
Goldman Sachs Adjusts Price Target on Colgate-Palmolive to $98 From $100, Maintains Buy Rating - marketscreener.com
Colgate-Palmolive India Launches Free Dental Check-Up Initiative with 63,000 Partner Dentists - scanx.trade
Allspring Global Investments Holdings LLC Has $2.82 Million Stock Position in Colgate-Palmolive Company $CL - MarketBeat
Colgate Makes Preventive Dental Care Accessible to All with FREE Dental Check-Ups - Editorji
Colgate-Palmolive (CL) – One of the 15 Best Low Volatility Blue Chip Stocks to Buy Now - Yahoo Finance
Toothpaste Buyers Could Cash In After $2.9M Settlement: Here's How - dailyvoice.com
Colgate-Palmolive (CL) Analyst Rating Updated by UBS | CL Stock News - GuruFocus
UBS Group Cuts Colgate-Palmolive (NYSE:CL) Price Target to $98.00 - MarketBeat
Colgate-Palmolive Company (NYSE:CL) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Colgate Palmolive Co Stock (CL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.46%
0.24%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):